Sunday, December 14, 2025
HomeIndustriesHealthcare

Healthcare

Kineta Presents New Preclinical Data and Phase 1/2 Clinical Trial Design of KVA12.1 at the Tumor Myeloid-Directed Therapies Summit

Kineta, Inc. ("Kineta" or the "Company"), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology, announced that it presented the...

DTx Leader Sidekick Enters Strategic Collaboration with Lilly to Support Patients with Breast Cancer

International digital therapeutics (DTx) innovator, Sidekick Health (www.sidekickhealth.com), announces an integrated digital therapeutics solution in conjunction with pharmaceutical company Eli Lilly and Company (www.lilly.com)...

Brand Institute Partners on Brand Name Development for European Commission Approved Treatment

Brand Institute is proud to announce having worked with Myovant Sciences in developing the brand name ORGOVYX, for an oral medication used to treat...

Fluent Biosciences and Nanocellect Announce Joint Collaboration

Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every researcher, and NanoCellect Biomedical, Inc., a leader in the...

FDA Authorizes Moderna and Pfizer-BioNTech COVID-19 Vaccines for Children Down to 6 Months of Age

The U.S. Food and Drug Administration authorized emergency use of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19...
0FansLike
0FollowersFollow
spot_img

Hot Topics